Results 251 to 260 of about 12,776,407 (326)

Comparing survival with vitamin K antagonists, low-molecular-weight heparin, and direct oral anticoagulants in patients with cancer-a systematic review and meta-analysis. [PDF]

Res Pract Thromb Haemost
Xirou V, Patel A, Altamirano MFA, Singh R, Gusdorf J, Barnum K, McNichol M, Ryu J, Zwicker JI, Chiasakul T, Patell R.   +10 more
europepmc   +1 more source

Impact of Inherited Thrombophilia on Pregnancy Complications and the Role of Low-Molecular-Weight Heparin Therapy: A Case-Control Study. [PDF]

Medicina (Kaunas)
Maglic D, Mandic-Markovic V, Mikovic Z, Maglic R, Anicic R, Mandic M.   +5 more
europepmc   +1 more source

Rivaroxaban versus low-molecular-weight heparin for venous thromboembolism prophylaxis: a systematic review of efficacy, safety, and cost-effectiveness. [PDF]

Front Pharmacol
Li B, Zhao L.
europepmc   +1 more source

Short-term outcomes of unfractionated heparin vs. low molecular weight heparin in trans-radial coronary angiography: a comparative study. [PDF]

Front Cardiovasc Med
Taha S, Ibrahim Sakr MIM, Abd El Salaam MSED, Ahmed MM, Abdelmegid MAF.   +4 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Heparin/low-molecular-weight-heparins

Reactions Weekly

semanticscholar   +6 more sources

Heparin and low-molecular-weight heparin

Thrombosis and Haemostasis, 2008
SummaryHeparin is one of the oldest biological medicines, and has an established place in the prevention and treatment of venous thrombosis. Low-molecular-weight heparins (LMWH) have been developed by several manufacturers and have advantages in terms of pharmacokinetics and convenience of administration.
Elaine Gray, Barbara Mulloy, Trevor W Barrowcliffe   +2 more
exaly   +3 more sources

Heparin and low-molecular-weight heparin: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.

Chest, 2004
J. Hirsh, R. Raschke
semanticscholar   +2 more sources

Low molecular weight heparins

Expert Opinion on Pharmacotherapy, 2000
Since its discovery, nearly 90 years, heparin has been used successfully for the treatment of thromboembolic processes. However, therapy with heparin has several important limitations. Most importantly, the poor predictability of its anticoagulant effects has led to the development of the low molecular weight heparins (LMWHs), which are derived from ...
O M, Aguilar, N S, Kleiman
openaire   +3 more sources

Heparin/low-molecular-weight-heparins

Reactions Weekly, 2023

semanticscholar   +2 more sources